{
  "page": 118,
  "value": [
    {
      "path": "_news/2021-06-20-israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs.md",
      "title": "Israel’s Immunai to use $215 mil. investment to develop, test new drugs",
      "excerpt": "Israeli-American biotech company Immunai is best known for its development of the world’s largest data atlas of clinically annotated single-cell immune data.",
      "sourceUrl": null,
      "webUrl": "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266",
      "originalUrl": "https://www.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266",
      "featuredContent": null,
      "highlight": null,
      "heat": null,
      "tags": null,
      "images": [
        {
          "url": "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/485949",
          "width": 640,
          "height": 428,
          "title": null,
          "attribution": null,
          "isCached": true
        }
      ],
      "content": "\r\n",
      "type": "article",
      "ampWebUrl": "https://m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp",
      "cdnAmpWebUrl": "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-and-wellness/israels-immunai-to-use-215-mil-investment-to-develop-test-new-drugs-683266/amp",
      "publishedDateTime": "2021-06-19T13:00:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Jerusalem Post Blogs",
        "domain": "jpost.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "AI"
      ]
    }
  ],
  "nextPage": null
}